| Strategies to prevent surgical site infections in acute care hospitals: 2014 update DJ Anderson, K Podgorny, SI Berríos-Torres, DW Bratzler, EP Dellinger, ... Infection Control & Hospital Epidemiology 35 (S2), S66-S88, 2014 | 1512 | 2014 |
| Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial PB Gilbert, DC Montefiori, AB McDermott, Y Fong, D Benkeser, W Deng, ... Science 375 (6576), 43-50, 2022 | 973 | 2022 |
| Clinical characteristics and morbidity associated with coronavirus disease 2019 in a series of patients in metropolitan Detroit G Suleyman, RA Fadel, KM Malette, C Hammond, H Abdulla, A Entz, ... JAMA network open 3 (6), e2012270-e2012270, 2020 | 793 | 2020 |
| Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 … VC Marconi, AV Ramanan, S de Bono, CE Kartman, V Krishnan, R Liao, ... The lancet Respiratory medicine 9 (12), 1407-1418, 2021 | 679 | 2021 |
| Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19 S Arshad, P Kilgore, ZS Chaudhry, G Jacobsen, DD Wang, K Huitsing, ... International journal of infectious diseases 97, 396-403, 2020 | 589 | 2020 |
| Early short-course corticosteroids in hospitalized patients with COVID-19 R Fadel, AR Morrison, A Vahia, ZR Smith, Z Chaudhry, P Bhargava, ... Clinical Infectious Diseases 71 (16), 2114-2120, 2020 | 507 | 2020 |
| Coronavirus disease 2019 in solid organ transplant: a multicenter cohort study OS Kates, BM Haydel, SS Florman, MM Rana, ZS Chaudhry, MS Ramesh, ... Clinical Infectious Diseases 73 (11), e4090-e4099, 2021 | 462 | 2021 |
| Safety and Durability of RBX2660 (Microbiota Suspension) for Recurrent Clostridium difficile Infection: Results of the PUNCH CD Study R Orenstein, E Dubberke, R Hardi, A Ray, K Mullane, DS Pardi, ... Clinical Infectious Diseases 62 (5), 596-602, 2016 | 196 | 2016 |
| Clinical characteristics and outcomes of COVID-19 in solid organ transplant recipients: a cohort study ZS Chaudhry, JD Williams, A Vahia, R Fadel, TP Acosta, R Prashar, ... American Journal of Transplantation 20 (11), 3051-3060, 2020 | 138 | 2020 |
| Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised … WH Self, U Sandkovsky, CS Reilly, DM Vock, RL Gottlieb, M Mack, ... The Lancet Infectious Diseases 22 (5), 622-635, 2022 | 125 | 2022 |
| Effect of subcutaneous casirivimab and imdevimab antibody combination vs placebo on development of symptomatic COVID-19 in early asymptomatic SARS-CoV-2 infection: a randomized … MP O’Brien, E Forleo-Neto, N Sarkar, F Isa, P Hou, KC Chan, BJ Musser, ... Jama 327 (5), 432-441, 2022 | 106 | 2022 |
| Intestinal Microbiota Transplantation, a Simple and Effective Treatment for Severe and Refractory Clostridium Difficile Infection H Zainah, M Hassan, L Shiekh-Sroujieh, S Hassan, G Alangaden, ... Digestive diseases and sciences 60, 181-185, 2015 | 106 | 2015 |
| Acute hypertriglyceridemia in patients with COVID‐19 receiving tocilizumab AR Morrison, JM Johnson, M Ramesh, P Bradley, J Jennings, ZR Smith Journal of Medical Virology 92 (10), 1791, 2020 | 94 | 2020 |
| A comparative study of the post-antifungal effect (PAFE) of amphotericin B, triazoles and echinocandins on Aspergillus fumigatus and Candida albicans EK Manavathu, MS Ramesh, I Baskaran, LT Ganesan, PH Chandrasekar Journal of Antimicrobial Chemotherapy 53 (2), 386-389, 2004 | 94 | 2004 |
| Clinical characteristics and predictors of survival in adults with coronavirus disease 2019 receiving tocilizumab AR Morrison, JM Johnson, KM Griebe, MC Jones, JJ Stine, LN Hencken, ... Journal of autoimmunity 114, 102512, 2020 | 73 | 2020 |
| Henry Ford COVID-19 Task Force. Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19 S Arshad, P Kilgore, ZS Chaudhry, G Jacobsen, DD Wang, K Huitsing, ... Int J Infect Dis 97 (396), e403, 2020 | 73 | 2020 |
| Characterization of BK polyomaviruses from kidney transplant recipients suggests a role for APOBEC3 in driving in-host virus evolution A Peretti, EM Geoghegan, DV Pastrana, S Smola, P Feld, M Sauter, ... Cell host & microbe 23 (5), 628-635. e7, 2018 | 73 | 2018 |
| Currently recommended BK virus (BKV) plasma viral load cutoff of ≥4 log10/mL underestimates the diagnosis of BKV‐associated nephropathy: a single transplant … S Hassan, C Mittal, S Amer, F Khalid, A Patel, R Delbusto, L Samuel, ... Transplant Infectious Disease 16 (1), 55-60, 2014 | 67 | 2014 |
| Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials C Axfors, P Janiaud, AM Schmitt, J van’t Hooft, ER Smith, NA Haber, ... BMC infectious diseases 21, 1-23, 2021 | 63 | 2021 |
| Efficacy, safety, and immunogenicity of a booster regimen of Ad26. COV2. S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled … K Hardt, A Vandebosch, J Sadoff, M Le Gars, C Truyers, D Lowson, ... The Lancet Infectious Diseases 22 (12), 1703-1715, 2022 | 53 | 2022 |
